The DOI matches its Crossref record; 263 of the 263 references it cites were found in a registry or an index.
Pathogenesis, diagnostics, and therapeutics for Alzheimer's disease: Breaking the memory barrier
Open accessAbstract
Alzheimer's disease (AD) is the most common cause of dementia and accounts for 60-70 % of all cases. It affects millions of people worldwide. AD poses a substantial economic burden on societies and healthcare systems. AD is a progressive neurodegenerative disorder characterized by cognitive decline, memory loss, and impaired daily functioning. As the prevalence of AD continues to increase, understanding its pathogenesis, improving diagnostic methods, and developing effective therapeutics have become paramount. This comprehensive review delves into the intricate mechanisms underlying AD, explores the current state of diagnostic techniques, and examines emerging therapeutic strategies. By revealing the complexities of AD, this review aims to contribute to the growing body of knowledge surrounding this devastating disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–263 of 263
Feigin, A., Evans, E. E., Fisher, T. L., Leonard, J. E., Smith, E. S., Reader, A., Mishra, V., Manber, R., Walters, K. A., Kowarski, L., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01919-8 · Cited by 67
Ferrando, R., & Damián, A. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.629442 · Cited by 66
Ohm, D. T., Fought, A. J., Martersteck, A., Coventry, C., Sridhar, J., Gefen, T. D., Weıntraub, S., Bigio, E. H., Mesulam, M. M., Rogalski, E. J., et al. (2020) · Brain Pathology · doi:10.1111/bpa.12902 · Cited by 65
Huber, N., Korhonen, S., Hoffmann, D. B., Leskelä, S., Rostalski, H., Remes, A. M., Honkakoski, P., Solje, E., & Haapasalo, A. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01384-8 · Cited by 65
Cognitive Rehabilitation in Alzheimer’s Disease: A Controlled Intervention Trial
Brueggen, K., Kasper, E., Ochmann, S. L., Pfaff, H., Webel, S., Schneider, W., & Teipel, S. J. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-160771 · Cited by 64
Pang, R., Wang, X., Pei, F., Zhang, W., Shen, J., Gao, X., & Chang, C. K. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190328 · Cited by 64
Wang, G., Initiative, A. D. N., Estrella, A., Hakim, O., Milazzo, P., Patel, S. S., Pintagro, C., Li, D., Zhao, R., Vance, D. E., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220397 · Cited by 61
Berchtold, N. C., Prieto, G. A., Phelan, M. J., Gillen, D. L., Baldi, P., Bennett, D. A., Buchman, A. S., & Cotman, C. W. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.02.012 · Cited by 60
Hellweg, R., Wirth, Y., Janetzky, W., & Hartmann, S. (2011) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2766 · Cited by 57
Gronwald, T., Alves, A. C. D. B., Murillo‐Rodríguez, E., Latini, A., Schuette, J., & Budde, H. (2019) · Journal of sport and health science/Journal of Sport and Health Science · doi:10.1016/j.jshs.2019.03.006 · Cited by 57
Diabetes: Risk factor and translational therapeutic implications for Alzheimer's disease
Cummings, J. L., Ortiz, A. A., Castellino, J., & Kinney, J. W. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15619 · Cited by 56
Reproductive Hormones Modulate Oxidative Stress in Alzheimer's Disease
Barron, A. M., Fuller, S. J., Verdile, G., & Martins, R. N. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.2047 · Cited by 55
Li, Z., Chen, Q., Liu, J., & Du, Y. (2020) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000507285 · Cited by 55
Jha, S. K., Jha, N. K., Kumar, D., Sharma, R., Shrivastava, A., Ambasta, R. K., & Kumar, P. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160623 · Cited by 53
FTDP-17 Mutations in Tau Alter the Regulation of Microtubule Dynamics
LeBoeuf, A. C., Levy, S. F., Gaylord, M. A., Bhattacharya, A., Singh, A. K., Jordan, M. A., Wilson, L., & Feinstein, S. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803519200 · Cited by 52
Ethical Considerations in Dementia Diagnosis and Care: AAN Position Statement
Chiong, W., Tsou, A. Y., Simmons, Z., Bonnie, R. J., Russell, J. A., Busl, K. M., CONWIT, R. A., Cruz‐Flores, S., Epstein, L. G., Graf, W. D., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000012079 · Cited by 52
Association Between Physical Activity and Risk of Disabling Dementia in Japan
Ihira, H., Sawada, N., Inoue, M., Yasuda, N., Yamagishi, K., Charvat, H., Iwasaki, M., & Tsugane, S. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.4590 · Cited by 51
Ehrhardt, S., Porsteinsson, A. P., Munro, C. A., Rosenberg, P. B., Pollock, B. G., Devanand, D. P., Mintzer, J. E., Rajji, T. K., Ismail, Z., Schneider, L. S. S., et al. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.06.4946 · Cited by 50
Yan, L., Li, H., Qian, Y., Zhang, J., Cong, S., Zhang, X., Wu, L., Wang, Y., Wang, M., & Yu, T. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1334887 · Cited by 50
Yun, Y. U. E., Hu, L., Qin-jie, T. I. A. N., JIANG, J.-M., Yi-long, D. O. N. G., Jin, Z., CHENG, Y.-H., Hong, X., Ge, Q.-S., & Ping-ping, Z. U. O. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00618.x · Cited by 49
Schelter, B. O., Shiells, H., Baddeley, T. C., Rubino, C. M., Ganesan, H., Hammel, J., Vuksanović, V., Staff, R. T., Murray, A. D., Bracoud, L., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190772 · Cited by 47
Mirkin, S., & Albensi, B. C. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1094233 · Cited by 46
Alzheimer’s disease, neural stem cells and neurogenesis: cellular phase at single-cell level
Kızıl, Ç., Coşacak, M. İ., & Bhattarai, P. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.268896 · Cited by 46
Magnetic Resonance Imaging to Detect Early Molecular and Cellular Changes in Alzheimer's Disease
Knight, M. J., McCann, B., Kauppinen, R. A., & Coulthard, E. J. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00139 · Cited by 45
Hill, M. D., Blanco, M.-J., Salituro, F. G., Bai, Z., Beckley, J. T., Ackley, M. A., Dai, J., Doherty, J., Harrison, B. L., Hoffmann, E. C., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00313 · Cited by 44
The Effectiveness of Reality Orientation in the Treatment of Alzheimer’s Disease
Camargo, C. H. F., Justus, F. F., & Retzlaff, G. (2015) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317514568004 · Cited by 43
VALZ‐Pilot: High‐dose valacyclovir treatment in patients with early‐stage Alzheimer's disease
Weidung, B., Hemmingsson, E., Olsson, J., Sundström, T., Blennow, K., Zetterberg, H., Ingelsson, M., Elgh, F., & Lövheim, H. (2022) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12264 · Cited by 43
Lök, N., Buldukoğlu, K., & Barçın, E. (2020) · Perspectives In Psychiatric Care · doi:10.1111/ppc.12472 · Cited by 42
Diagnostic biomarkers in Alzheimer’s disease
Andersen, E., Casteigne, B., Chapman, W. D., Creed, A., Foster, F., Lapins, A., Shatz, R., & Sawyer, R. P. (2021) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2021.100041 · Cited by 42
Therapeutics of Alzheimer’s Disease: Recent Developments
Burns, S., Selman, A., Sehar, U., Rawat, P., Reddy, A. P., & Reddy, P. H. (2022) · Antioxidants · doi:10.3390/antiox11122402 · Cited by 40
Gautam, D., Naik, U. P., Naik, M. U., Yadav, S. K., Chaurasia, R. N., & Dash, D. (2023) · Biomolecules · doi:10.3390/biom13111609 · Cited by 40
Stem Cell Therapy for Alzheimer’s Disease: A Scoping Review for 2017–2022
Duan, Y., Lyu, L., & Zhan, S. (2023) · Biomedicines · doi:10.3390/biomedicines11010120 · Cited by 39
Acosta, D. M., Mancinelli, C. D., Bracken, C., & Eliezer, D. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101442 · Cited by 37
Physical Activity Rewires the Human Brain against Neurodegeneration
Santiago, J. A., Quinn, J. P., & Potashkin, J. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116223 · Cited by 37
Vallés-Saiz, L., Ávila, J., & Hernández, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311144 · Cited by 35
The neuroprotective mechanism of action of the multimodal drug ladostigil
Weinreb, O., Amit, T., Bar‐Am, O., Yogev‐Falach, M., & Youdim, M. B. H. (2008) · Frontiers in bioscience · doi:10.2741/3069 · Cited by 35
Hernandez, G. D., Solinsky, C. M., Mack, W. J., Kono, N., Rodgers, K. E., Wu, C., Mollo, A. R., Lopez, C. M., Pawluczyk, S., Bauer, G., et al. (2020) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12107 · Cited by 35
Stem cell‐ and gene‐based therapies as potential candidates in Alzheimer's therapy
Hosseini, S. A., Mohammadi, R., Noruzi, S., Mohamadi, Y., Azizian, M., Mousavy, S. M., Ghasemi, F., Hesari, A., Sahebkar, A., Salarinia, R., et al. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27202 · Cited by 34
Hua, X., Church, K. J., Walker, W., L’Hostis, P., Viardot, G., Danjou, P., Hendrix, S., & Moebius, H. J. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215511 · Cited by 31
Kim, D. Y., Choi, S. H., Lee, J., Kim, H. J., Kim, H., Lee, J. E., Shin, J. Y., & Lee, P. H. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200026 · Cited by 30
Hippocampal and entorhinal atrophy in mild cognitive impairment: Prediction of Alzheimer disease
Devanand, D. P., Pradhaban, G., Liu, X., Khandji, A., De Santi, S., Segal, S., Rusinek, H., Pelton, G. H., Honig, L. S., Mayeux, R. P., et al. (2022) · Columbia Academic Commons (Columbia University) · doi:10.7916/qbbr-9x61 · Cited by 30
Kavková, M., Zikmund, T., Kala, A., Šalplachta, J., Pena, S. L. P., Kaiser, J., & Ježek, K. (2021) · Scientific Reports · doi:10.1038/s41598-021-84579-x · Cited by 29
Biological and disease hallmarks of Alzheimer’s disease defined by Alzheimer’s disease genes
Murakami, S., & Lacayo, P. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.996030 · Cited by 29
Acetylcholine deficit causes dysfunctional inhibitory control in an aging-dependent manner
Sabandal, P. R., Saldes, E. B., & Han, K. (2022) · Scientific Reports · doi:10.1038/s41598-022-25402-z · Cited by 28
Genetic Therapies for Alzheimer’s Disease: A Scoping Review
Lennon, M. J., Rigney, G., Raymont, V., & Sachdev, P. S. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215145 · Cited by 26
Valotassiou, V. J., Papatriantafyllou, J. D., Sifakis, N., Tzavara, C. K., Tsougos, I., Psimadas, D., Fezoulidis, I. V., Kapsalaki, E. Z., Hadjigeorgiou, G. M., & Georgoulias, P. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150068 · Cited by 25
Hashmi, M. U., Ahmed, R., Mahmoud, S., Ahmed, K., Bushra, N. M., Ahmed, A., Elwadie, B., Madni, A., Saad, A. B., & Abdelrahman, N. G. (2023) · Cureus · doi:10.7759/cureus.46732 · Cited by 24
Darmanthé, N., Initiative, A. D. N., Tabatabaei‐Jafari, H., & Cherbuin, N. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210092 · Cited by 23
The Effects of Physical Running on Dendritic Spines and Amyloid-beta Pathology in 3xTg-AD Male Mice
Xu, B., He, Y., Liu, L., Ye, G., Chen, L., Wang, Q., Chen, M. J., Chen, Y., & Long, D. (2022) · Aging and Disease · doi:10.14336/ad.2022.0110 · Cited by 21
Wenzel, T. J., Murray, T. E., Noyovitz, B., Narayana, K., Gray, T. E., Le, J. M., He, J., Simtchouk, S., Gibon, J., Alcorn, J., et al. (2022) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2022.103804 · Cited by 18
Сергеевич, А. А., Ryazanova, M. V., Baranich, T. I., Stavrovskaya, A. V., Rozanova, N. A., Novikova, S. V., & Salmina, A. B. (2023) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-023-05859-2 · Cited by 18
Mcaulay, J., & Streater, A. (2018) · Dementia · doi:10.1177/1471301218808986 · Cited by 17
Valotassiou, V. J., Papatriantafyllou, J. D., Sifakis, N., Tzavara, C. K., Tsougos, I., Kapsalaki, E. Z., Hadjigeorgiou, G. M., & Georgoulias, P. (2012) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e3283599983 · Cited by 16
Deep brain stimulation in Alzheimer's disease
Fontaine, D., & Santucci, S. (2021) · International review of neurobiology · doi:10.1016/bs.irn.2021.06.005 · Cited by 14
Daou, L., Alayli, A. E., Constantinos, F., Dib, G., & Barakat, M. (2023) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2023.100069 · Cited by 14
Davidowitz, E. J., Lopez, P., Jimenez, H. T., Adrien, L. R., Davies, P., & Moe, J. G. (2023) · PLoS ONE · doi:10.1371/journal.pone.0286523 · Cited by 14
Abed, S. S., Hamdan, F. B., Hussein, M. M., & Al-Mayah, Q. S. (2023) · Journal of Medicine and Life · doi:10.25122/jml-2022-0251 · Cited by 13
McDarby, M., Russell, D., King, L., Kozlov, E., & Luth, E. A. (2023) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/10499091231176298 · Cited by 13
Vasconcelos, L. D. G., Brucki, S. M. D., Jackowski, A. P., & Bueno, O. F. A. (2009) · Dementia & Neuropsychologia · doi:10.1590/s1980-57642009dn30400002 · Cited by 12
Valotassiou, V. J., Angelidis, G., Psimadas, D., Tsougos, I., & Georgoulias, P. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-05077-2 · Cited by 10
Sanfilippo, C., Musumeci, G., Castrogiovanni, P., Fazio, F., Volti, G. L., Barbagallo, I. A., Maugeri, G., Ravalli, S., Imbesi, R., & Rosa, M. D. (2021) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2021.101934 · Cited by 10
Kielbasa, W., Shcherbinin, S., Goldsmith, P., Phipps, K. M., Biglan, K., Mancini, M., Russell, D., Constantinescu, C. C., Gunn, R. N., Nuthall, H. N., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.057774 · Cited by 9
Kwon, H. S., Koh, S., Choi, S. H., Jeong, J. H., Na, H. R., Lee, C., Yang, Y., Lee, A. Y., Lee, J., Park, K. W., et al. (2023) · Dementia and Neurocognitive Disorders · doi:10.12779/dnd.2023.22.3.100 · Cited by 5
Research works printed but not linked: 21
- Suzuki, 2023, Specific Mutations near the Amyloid Precursor Protein Cleavage Site Increase γ-Secretase Sensitivity and Modulate Amyloid-β Production, Int J. Mol. Sci. [Internet], 24, 24
- Fu, 2017, Role of microglial amylin receptors in mediating beta amyloid (Aβ)-induced inflammation, J. Neuroinflamm. [Internet], 14, 1
- Cha, 2012, Mitochondria-Specific Accumulation of Amyloid β Induces Mitochondrial Dysfunction Leading to Apoptotic Cell Death, PLoS One [Internet], 7
- Li, 2015, Different mechanisms of apolipoprotein E isoform–dependent modulation of prostaglandin E2 production and triggering receptor expressed on myeloid cells 2 (TREM2) expression after innate immune activation of microglia, FASEB J. [Internet]
- Mecca, 2022, Synaptic density and cognitive performance in, Alzheimer’S. Dis.: A PET Imaging Study [11C]UCB-J. Alzheimer’S. Dement. [Internet], 18, 2527
- Varghese, 2013, A review of neuroimaging biomarkers of Alzheimer’s disease., Neurol. Asia [Internet]
- Wu, 2022, Computed Tomography Density and β-Amyloid Deposition of Intraorbital Optic Nerve May Assist in Diagnosing Mild Cognitive Impairment and Alzheimer’s Disease: A 18F-Flutemetamol Positron Emission Tomography/Computed Tomography Study, Front Aging Neurosci. [Internet]
- Dumurgier, 2015, Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: A multicentric study, Alzheimers Res Ther. [Internet], 7, 1
- Hansson, 2023, Blood biomarkers for Alzheimer’s disease in clinical practice and trials, Nat. Aging, 3, 10.1038/s43587-023-00403-3 · DOI · Paper page
- Fabrizio, 2021, Artificial Intelligence for Alzheimer’s Disease: Promise or Challenge?, Diagn. [Internet], 10.3390/diagnostics11081473 · DOI
- Kumar, 2015, A review on Alzheimer’s disease pathophysiology and its management: An update, Vol. 67, 195
- Parums, 2021, Editorial: Targets for Disease-Modifying Therapies in Alzheimer’s Disease, Including Amyloid β and Tau Protein, Med Sci. Monit. [Internet]
- Vaz, 2020, Alzheimer’s disease: Recent treatment strategies, Vol. 887
- Tai, 2023, APNmAb005, an anti-tau antibody targeting synaptic tau oligomers, in Phase 1 for treatment of Alzheimer’s Disease and primary tauopathies, Alzheimer’S. Dement. [Internet], 10.1002/alz.076888 · doi:10.1002/alz.076888
- Ward, 2021, A phase 1 study of AL002 in healthy volunteers, Alzheimer’S. Dement. [Internet], 10.1002/alz.054669 · DOI
- Reich, 2018, Therapeutic Advantages of Dual Targeting of PPAR-δ and PPAR-γ in an Experimental Model of Sporadic Alzheimer’s Disease, J. Park. Dis. Alzheimers Dis., 5
- Armijo, 2021, Induced Pluripotent Stem Cell-Derived Neural Precursors Improve Memory, Synaptic Pathol. Abnorm. a Mouse Model Alzheimer’S. Dis., Vol. 10
- Hashmi, 2023, Exploring Methylene Blue and Its Derivatives in Alzheimer’s Treatment: A Comprehensive Review of Randomized Control Trials, Cureus [Internet], 10.7759/cureus.46732 · DOI
- Fariba, 2023, Deep Brain Stimul. Encycl. Mov. Disord., Three-Vol. Set. [Internet].
- Gordon, 2024, Vulnerability in Research: Basic Ethical Concepts and General Approach to Review. Ochsner Journal [Internet], 2020 Mar. 20 [cited
- Shah, 2023, Informed Consent, N. Engl. J. Med [Internet], 376, 863
Cited by
ALNasser, M. N., Alboraiy, G. M., Alsowig, E. M., & Alqattan, F. M. (2025) · Brain Sciences · doi:10.3390/brainsci15020215 · Cited by 35
“Early symptoms include memory problems, sleep issues, and mood disorders, progressing to difficulties in walking and communicating in later stages [4].”
Metadata
- Authors
- Kamatham, P. T., Shukla, R., Khatri, D. K., & Vora, L. K.
- Venue
- Ageing Research Reviews
- Publisher
- Elsevier BV
- Published
- 2024-11
- Volume
- 101
- Pages
- 102481
- ISSN
- 1568-1637 (ISSN-L)
- OpenAlex
- W4402169022
- Cited by
- 371
- References
- 263
- FWCI
- 28.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Funders
- National Institute of Pharmaceutical Education and Research, Raebareli
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.